SYNGAP1 and amyotrophic lateral sclerosis: Thus, the isogenic model of human-induced pluripotent stem cell (iPSC)-derived motor neurons were used to validate the pathogenic mechanism of the novel SYNGAP1 variant in human ALS patients.